StratGraph
Companies / Industrials
JCI

Johnson Controls

Building Products

Building ProductsAnalysis in progress
In progress

We are decoding this company's strategy and relationships

New analyses are published every weekday. Founding members get them first.

Business at a glance

Operating-health scores describe reported fundamentals on a 0–100 scale. They are not a rating of the stock. How they work

Operating health65
Growth48
Profitability50
Cash generation76
Balance sheet49
Dilution control100
Key ratios and five-year financials
Latest quarter revenue YoY (2026-06-30)9.3%Revenue growth (FY)8.8%Revenue CAGR (3y)4.7%Gross margin37.1%Operating margin—Net margin11.1%Free cash flow margin13.3%R&D / revenue1.0%Stock comp / revenue0.5%Net debt / operating cash flow2.24xCurrent ratio0.90Diluted share count change-6.6%
Fiscal year endingFY 2022-09FY 2023-09FY 2024-09FY 2025-09FY 2026-09
Revenue$20.6B$22.3B$23.0B$23.6B$25.7B
Gross profit$7.1B$7.8B$8.1B$8.6B$9.5B
Net income$1.5B$1.8B$1.7B$3.3B$2.9B
Operating cash flow$1.2B$1.9B$1.6B$2.6B$3.9B
Capital expenditure$487M$446M$494M$434M$465M
Free cash flow$750M$1.4B$1.1B$2.1B$3.4B
R&D$236M$251M$267M$273M$265M
Stock-based comp$98M$107M$107M$140M$124M
Buybacks$1.4B$625M$1.2B$6.0B$1.5B
Dividends$916M$980M$1.0B$976M$976M
Cash$2.0B$828M$606M$379M$618M
Total debt$8.1B$8.8B$9.5B$9.9B$9.3B
Equity$16.3B$16.5B$16.1B$12.9B$13.6B

StratGraph publishes general, impersonal research about public companies based on public filings. It is not investment advice, not a recommendation to buy, sell or hold any security, and not tailored to any reader's circumstances. Content may contain errors and may be partly generated with AI tools; verify against the original filings, which are linked. Authors may not trade securities discussed within the window set by our trading policy. Full disclaimer.